Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic | BMC Infectious Diseases
Study design A prospective cohort study was conducted that enrolled patients with RR/MDR-TB between January and December 2022 in seven drug-resistant TB units in the Dominican Republic. The research protocol and data collection tools were developed using the Short all-Oral Regimens for Rifampicin-resistant Tuberculosis (ShoRRT) research package proposed by TDR [11], and adapted to the … Read more